Join the Gemcitabine group to help and get support from people like you.
Gemcitabine News
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
THURSDAY, Aug. 21, 2025 – For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical gemcitabine-releasing system, TAR-200 ...
Device Eliminates Bladder Cancers in 4 of 5 Cases
MONDAY, Aug. 18, 2025 — A new implant eliminated bladder cancer in more than 4 out of 5 high-risk cases, new clinical trial results show. The miniature pretzel-shaped device, dubbed TAR-200, slowly r...
FDA Approves Merck’s Keytruda (pembrolizumab) Plus Gemcitabine and Cisplatin as Treatment for Patients With Locally Advanced Unresectable or Metastatic Biliary Tract Cancer
RAHWAY, N.J.--(BUSINESS WIRE) November 1, 2023 – Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Medwatch Alert: Injectable Products by Mylan: Recall - Presence of Particulate Matter
including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot...
Further information
Related condition support groups
Ovarian Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Breast Cancer